Biochemical markers of myocardial damage for early diagnosis and prognosis in patients with acute coronary syndromes

Upsala Journal of Medical Sciences

Volumn 101, Issue 3, 1996, Pages 193-232

  Lindahl, Bertil ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; CREATINE KINASE; DALTEPARIN; ENDOTHELIN; ISOENZYME; MYOGLOBIN; TROPONIN; TROPONIN T;

AGED; BLOOD; COHORT ANALYSIS; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; REVIEW; TIME; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANTICOAGULANTS; BIOLOGICAL MARKERS; COHORT STUDIES; CREATINE KINASE; DALTEPARIN; ENDOTHELINS; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOGLOBIN; PROGNOSIS; TIME FACTORS; TROPONIN; TROPONIN T;

EID: 0030346921     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009739609178922     Document Type: Article

References (210)

1. Karlson BW, Herlitz J, Pettersson P, Ekvall HE, Hjalmarson A Patients admitted to the emergency room with symptoms indicative of acute myo-cardial infarction. J Intern Med 1991; 230: 251-8.
2. Karlson BW, Herlitz J, Wikiund O, Richter A, Hjalmarson A, Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room. Am J Cardiol 1991; 68: 171-5.
3. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coro-nary artery disease and the acute coro-nary syndromes (second of two parts). N Engi J Med 1992; 326: 310-18.
4. Rutherford JD, Braunwald E. Chronic ischemic heart disease. In: Braunwald E, ed. Heart disease. A textbook of cardiovascular medicine. Philadelphia. WB Saunders Company, 1992: 1293-1364.
5. Hypertension and coronary heart disease. Classification and criteria for epidemiological studies. World Health Organization Technical Series 168 1959: 3.
6. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 1992; 326: 242-50.
7. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coro-nary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983; 50: 127-34.
8. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myo-cardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985; 53: 363-73.
9. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71.
10. Alderman EL, Corley SD, Fisher LD, et al. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investi-gators and Staff. J Am Coll Cardiol 1993; 22: 1141-54.
11. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 56-62.
12. Giroud D, Li JM, Urban P, Meier B, Rutishauer W Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol 1992; 69: 729-32.
13. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemo-static factors and the risk of myo-cardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombo-sis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332: 635-41.
14. Maseri A, L'Abbate A, Baroldi G, et al. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of "preinfarction" angina. N Engl J Med 1978; 299: 1271-7.
15. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Pro-gressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
16. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial. infarc-tion: value of combined thrombolytic and vasodilatory therapy. N Engl J Med 1987; 317: 1055-9.
17. de Feyter PJ, Ozaki Y, Baptista J, et al. Ischemia-related lesion characteristics in patients with stable or unstable angina. A study with intracoronary angioscopy and ultrasound. Circulation 1995; 92: 1408-13.
18. Ambrose JA. Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarc-tion: if the substrate is similar, why is the clinical presentation different? J Am Coll Cardiol 1992; 19: 1653-8.
19. DeWood MA, Stifter WF, Simpson CS, et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 1986; 315: 417-23.
20. Charney R, Cohen M. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J 1993; 126: 937-45.
21. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlu-sion during the early hours of transmural infarction. N Engl J Med 1980; 303: 897-902.
22. PhibbsB. "Transmural"versus"subendocardial" myocardial infarc-tion:anelectrocardiographic myth J Am Coll Cardiol 1983; 1: 561-564.
23. Cohen M, Xiong J, Parry G, et al. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. J Am Coll Cardiol 1993; 22: 1338-43.
24. Betriu A, Heras M, Cohen M, Fuster V. Unstable angina: outcome according to clinical presentation. J Am Coll Cardiol 1992; 19: 1659-63.
25. Anderson HV, Cannon CP, Stone PH, et al One-year results of the Thrombo-lysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized com-parison of tissue-type plasminogen activator versus placebo and early in-vasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 1995; 26:1643-50.
26. André-Fouet X, Pillot M, Leizorovicz A, Finet G, Gayet C, Milon H. "Non-Q wave", alias "nontransmural", myo-cardial infarction. a specific entity. Am Heart J 1989; 117: 892-900.
27. Nicod P, Gilpin E, Dittrich H, et al Short- and long-tern clinical outcome after Q wave and non-Q wave myo-cardial infarction in a large patient population. Circulation 1989; 79: 528-536.
28. Berger CJ, Murabito JM, Evans JC, Anderson KM, Levy D. Prognosis after first myocardial infarction. Compari-son of Q-wave and non-Q-wave myo-cardial infarction in the Framingham Heart Study. JAMA 1992, 268:1545-51.
29. Lincoff AM, Topol EJ. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993; 88: 1361-74
30. Koren GT, Hasin Y, Appelbaum D, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous strepto-kinase. N Engl J Med 1985; 313: 1384-89.
31. Nidorf SM, Siu SC, Galambos G, Weyman AE, Picard MH. Benefit of late coronary reperfusion on ventri-cular morphology and function after myocardial infarction. J Am Coll Cardiol 1993; 21. 683-91.
32. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all rando-mised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
33. Rawles J. What is the likely benefit of earlier thrombolysis? Eur Heart J 1996; 17: 991-95.
34. de Boer MJ, Hoorntje JC, Ottervanger JP, Reiffers S, Suryapranata H, Zijlstra F. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 1994; 23: 1004-8.
35. Vaitkus PT. Percutaneous transluminal coronary angioplasty versus thrombo-lysis in acute myocardial infarction: a metaanalysis. Clin Cardiol 1995; 18: 35-8.
36. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 1. 349-360.
37. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico(GISSI). Effectiveness of intravenous thrombolytic treatment in acute myo-cardial infarction Lancet 1986; 2: 349-360.
38. Langer A, Goodman S, Topol E, et al. Late assessment of thrombolytic Efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction. J Am Coll Cardiol 1996; 27. 1327-32.
39. Karlsson J-E, Berglund U, Björkholm A, et al Thrombolysis with recombi-nant human tissue-type plasminogen activator during instability in coronary artery disease: Effect on myocardial ischemia and need for coronary re-vascularization. Am Heart J 1992; 124: 1419-26.
40. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994; 89: 1545-56.
41. Lewis D, JW D, Archibald D, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983; 309: 396-403.
42. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-30.
43. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarc-tion, and stroke by prolonged anti-platelet therapy in various categories of patients. Br Med J 1994; 308: 81-106.
44. Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Synd-romes Research Group. Circulation 1994; 89: 81-8.
45. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988, 319: 1105-1111.
46. Dunn CJ, Sorkin EM. Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders. Drugs 1996; 52: 276-305
47. Fragmin during instability in coronary artery disease (FRISC) study group. Low molecular weight heparin during instability in coronary artery disease. Lancet 1996; 347: 561-68.
48. The global use of strategies to open occluded coronary arteries (GUSTO) IIb investigateors. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996; 335: 775-82.
49. Antman EM, for the TIMI 9B investigators. Hirudin in acute myo-cardial infarction. Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial. Circulation 1996; 94: 911-21.
50. Théroux P, Waters D, Lam J, et al Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992; 327: 141-5.
51. Gold HK, Torres FW, Garabedian HD, et al. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris J Am Coll Cardiol 1993; 21: 1039-47.
52. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarc-tion. N Engl J Med 1990; 323: 147-52.
53. Cohen M, Adams PC, Hawkins L, Bach M, Fuster V. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myo-cardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). Am J Cardiol 1990; 66. 1287-92.
54. Rahimtola SH, Nunley D, Grunkemeir G, Tepley J, Lampert L, Starr A. Ten-year survival after coronary bypass surgery for unstable angina. N Engl J Med 1983; 308: 676-81.
55. Myler RK, Shaw RE, Stertzer SH, et al. Unstable angina and coronary angio-plasty. Circulation 1990; 82: 1188-1195.
56. Luchi R, Scott S, Deupree R, and the principal investigators and their associates of veterans administration cooperative study no. 28. Comparison of medical and surgical treatment for unstable angina pectoris. N Engl J Med 1987; 316: 977-84.
57. Karmen A, Wroblewski F, LaDue JS. Transaminase activity in human blood. J Clin Invest 1954; 34: 126-33.
58. Wroblewski F, LaDue JS. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 1955; 90: 210-3.
59. Dreyfus JC, Schapira G, Resnais J, Scebat L. La créatine-kinase sérique dans le diagnostic de l'infarctus myocardique. Rev Franc Etudes Clin Biol 1960; V: 386-387.
60. Roberts R. The two out of three criteria for diagnosis of infarction. Is it passe? Chest 1984; 86: 511-13.
61. Adams Jd, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88: 750-63.
62. Spieckermann PG, Nordbeck H, Preusse CJ. From heart to plasma. In: Hearse DJ, ed. Enzymes in cardiology. Chichester John Wiley & sons, 1979: 81-95.
63. van Kreel B, van der Veen F, Willems GM, Hermens WT. Circulatory models in assessment of cardiac enzyme release in dogs. Am J Physiol 1993; 264: H747-54.
64. Piper HM, Schwartz P, Spahr R, Hutter JF, Spieckermann PG. Early enzyme release from myocardial cells is not due to irreversible cell damage J Mol Cell Cardiol 1984; 16. 385-8.
65. Heyndrickx GR, Amano J, Kenna T, et al. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol 1985; 6: 1299-303.
66. Remppis A, Scheffold T, Greten J, et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 1995; 27: 793-803.
67. Mair J, Dienstl F, Puschendorf B. Cardiac troponin T in the diagnosis of myocardial injury. Crit Rev Clin Lab Sci 1992; 29: 31-57.
68. Rabitzsch G, Mair J, Lechleitner P, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995; 41 966-78.
69. Mair J, Thome-Kromer B, Wagner I, et al. Concentration time courses of tro-ponin and myosin subunits after acute myocardial infarction. Coron Artery Dis 1994; 5: 865-872.
70. Sobel BE, Markham J, Karlsberg RP, Roberts R. The nature of dis-appearance of creatine kinase from the circulation and its influence on enzymativ estimation of infarct size. Circ Res 1977; 41: 836-844.
71. Clark GL, Robison AK, Gnepp DR, Roberts R, Sobel BE. Effects of lymphatic transport of enzyme on plasma creatine kinase time-activity curves after myocardial infarction in dogs. Circ Res 1978; 43: 162-169.
72. Blanke H, von Hardenberg D, Cohen M, et al. Paterns of creatine kinase release during acute myocardial infarc-tion after nonsurgival reperfu-sion: Comparison with conventional treat-ment and correlation with infarct size. J Am Coll Cardiol 1984; 3 675-680.
73. Roberts R, Sobel BE. The distribution, inactivation and clearance of enzymes. In: Hearse DJ, ed. Enzymes in Cardio-logy Chichester: John Wiley & sons, 1979: 97-114.
74. Pesce MA. The CK and LD macro-enzymes. Lab Management 1984; 22 29-41.
75. Gerhardt W, Bullock D, Duggan P, et al. ECCLS standards for enzyme determinations. Creatine Kinase, Aspartate Aminotransferase, Alanine Aminotransferase and gamma-Glutamyltransferase. Klinisk Kemi i Norden (ed K. Hellsing) 1990; suppl vol 2: 5-88.
76. Gerhardt W, Ljungdahl L, Borjesson J, et al. Creatine kinase B-subunit activity in human serum. I Development of an immunoinhibition method for routine determination of S-creatine kinase B-subunit activity. Clin Chim Acta 1977; 78: 29-41.
77. Wu AH, Gornet TG, Harker CC, Chen HL. Role of rapid immunoassays for urgent ("stat") determinations of creatine kinase isoenyme MB. Clin Chem 1989; 35: 1752-6.
78. Puleo PR, Guadagno PA, Roberts R, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 1990; 82: 759-64
79. Klocke FJ, Copley DP, Krawczyk JA, Reichlin M. Rapid renal clearance of immunoreactive canine plasma myo-globin. Circulation 1982; 65: 1522-1528.
80. Groth T, Sylvén C. Myoglobin kinetics in patients suffering from acute myocardial infarction in its early phase - as studied by the single injection methodw. Scand J Clin Lab Invest 1981; 41: 79-85.
81. Roxin L-E, Venge P, Friman G, Hallgren R Radioimmuneassays of human myoglobin in serum and urine. Scand. J Clin Lab Invest 1979; 39: 37-46.
82. Mair J, Artner DE, Lechleitner P, et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 1992; 68: 462-8.
83. Hein S, Scheffold T, Schaper J. Ischemia induces early changes to cyto-skeletal and contractile proteins in diseased human myocardium. J Thorac Cardiovasc Surg 1995; 110: 89-98.
84. Katus HA, Scheffold T, Remppis A, Zehlein J. Proteins of the troponin complex Laboratory Medicine 1992; 23: 311-17.
85. Saggin L, Gorza L, Ausoni S, Schiaffino S. Cardiac troponin T in developing, regenerating and denervated rat skeletal muscle. Development 1990; 110: 547-54.
86. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Infra-cellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and non-reperfused myocardial infarction. Am J Cardiol 1991; 67: 1360-7.
87. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991;83.902-12.
88. Katus HA, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immuno-assay of cardiac troponin T. Clin Chem 1992; 38: 386-93.
89. Müller-Bardoff M, Müller G, Hallermayer K, et al. Development and characterization of a specific immunoassay for cardiac troponin T. Eur Heart J 1994; 15: 4 (abstract).
90. Adams JE, Schechtman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute myocardial infarc-tion by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40: 1291-95.
91. Mair J, Genser N, Morandell D, et al Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clinica Chimica Acta 1996; 245: 19-38.
92. Larue C, Calzolari C, Bertinchant JP, Leclercq F, Grolleau R, Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993; 39: 972-9.
93. Sox HC, Blatt MA, Higins MC, Marton KI. Medical decision making Boston: Butterworths, 1988.
94. Groth TL, Ljunghall S, De Verdier CH. Optimal screening for patients with hyperparathyroidism with use of serum calcium observations. A decision-theoretical analysis. Scand J Clin Lab Invest 1983; 43: 699-707.
95. Cebul RD, Hershey JC, Williams SV. Using multiple tests: series and parallel approaches. Clin Lab Med 1982; 2: 871-90.
96. Leung FY, Galbraith LV, Jablonsky G, Henderson AR. Re-evaluation of the diagnostic utility of serum total creatine kinase and creatine kinase-2 in myocardial infarction. Clin Chem 1989; 35: 1435-40.
97. Zweig MH, Campbell G. Receiver-operating characteristics (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39 561-77.
98. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommenda-tions based on a quantitative analysis. Ann Intern Med 1986; 105: 221-33.
99. Mair J, Artner DE, Dienstl A, et al. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. Am J Cardiol 1991; 68: 1545-50.
100. Bhayana V, Henderson AR. Bio-chemical markers of myocardial damage. Clin Biochem 1995; 28: 1-29.
101. Roxin LE, Cullhed I, Groth T, Hallgren T, Venge P. The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction. Acta Med Scand 1984; 215: 417-25.
102. Collinson PO, Ramhamadany EM, Rosalki SB, et al. Diagnosis of acute myocardial infarction from sequential enzyme measurements obtained within 12 hours of admission to hospital. J Clin Pathol 1989; 42: 1126-31.
103. Wu AH, Gornet TG, Bretaudiere JP, Panfili PR Comparison of enzyme immunoassay and immunoprecipita-tion for creatine kinase MB in diagnosis of acute myocardial infarction. Clin Chim 1985; 31: 470-474.
104. Kock TR, Mehta UJ, Nipper HC. Clinical and analytical evaluation of kits for measurements of creatine kinase isoenzyme MB. Clim Chem 1986; 32: 186-191.
105. Wu AH, Valdes RJ, Apple FS, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarc-tion. Clin Chem 1994; 40: 900-7.
106. McComb JM, McMaster EA, MacKenzie G, Adgey AA. Myoglobin and creatine kinase in acute myocardial infarction. Br Heart J 1984; 51: 189-94.
107. Wu AH, Lane PL. Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases. Clin Chem 1995, 41: 1228-33.
108. Lee HS, Cross SJ, Garthwaite P, et al. Comparison of the value of novel rapid measurement of myoglobin, creatine kinase, and creatine kinase-MB with the electrocardiogram for the diagnosis of acute myocardial infarc-tion. Br Heart J 1994; 71: 311-5.
109. Bakker AJ, Koelemay MJ, Gorgels JP, et al. Troponin T and myoglobin at ad-mission value of early diagnosis of acute myocardial infarction. Eur Heart J 1994; 15: 45-53
110. Marin MM, Teichman SL. Use of rapid serial sampling of creatine kinase MB for very early detection of myo-cardial infarction in patients with acute chest pain. Am Heart J 1992, 123: 354-61.
111. Van Blerk M, Maes V, Huyghens L, Derde MP, Meert R, Gorus FK. Analytical and clinical evaluation of creatine kinase MB mass assay by IMx: comparison with MB isoenzyme activity and serum myoglobin for early diagnosis of myocardial infarction. Clin Chem 1992; 38: 2380-6.
112. Bakker AJ, Koelemay MJW, Gorgels JPMC, et al. Failure of new biochemical markers to exclude acute myocardial infarction at admission. Lancet 1993; 342: 1220-22.
113. Antman EM, Grudzien C, Sacks DB. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA 1995; 273: 1279-82.
114. Puleo PR, Meyer D, Wathen C, et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331: 561-6.
115. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarc-tion. Clin Chem 1992; 38: 2203-14
116. Lessem J, Johansson BW, Nosslin B, Thorell J. Myocardial scintigraphy with 99mTc-pyrophosphate in patients with unstable angina pectoris. Acta Med Scand 1978; 203: 491-5.
117. Thygesen K, Hørder M, Krøll L, Hyltoft Petersen P, Haghfelt T. Creatine kinase and creatine kinase B-subunit in stable and unstable angina pectoris. Eur J Clin Invest 1986;16:1-4.
118. Botker HE, Ravkilde J, Sogaard P, Jorgensen PJ, Horder M, Thygesen K. Gradation of unstable angina based on a sensitive immunoassay for serum creatine kinase MB. Br Heart J 1991; 65: 72-6.
119. Isakov A, Shapira I, Burke M, Almog C. Serum myoglobin levels in patients with ischemic myocardial insult. Arch Intern Med 1988; 148: 1762-5.
120. Katus HA, Diederich KW, Hoberg E, Kubler W. Circulating cardiac myosin light chains in patients with angina at rest: identification of a high risk subgroup. J Am Coll Cardiol 1988; 11: 487-93.
121. Gerhardt W, Katus H, Ravkilde J, et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem 1991; 37: 1405-11.
122. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146-50.
123. Markenvard J, Dellborg M, Jagenburg R, Swedberg K. The predictive value of CKMB mass concentration in unstable angina pectoris: preliminary report J Intern Med 1992; 231: 433-6.
124. Ravkilde J, Horder M, Gerhardt W, et al. Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest 1993; 53: 677-85.
125. Pettersson T, Ohlsson O, Tryding N. Increased CKMB (mass concentration) in patients without traditional evidence of acute myocardial infarc-tion. A risk indicator of coronary death. Eur Heart J 1992; 13: 1387-92.
126. Ravkilde J, Nissen H, Hörder M, Thygesen K. Independent prognostic value of serum creatine kinase iso-enzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol 1995; 25: 574-81.
127. White RD, Grande P, Califf L, Palmen ST, Califf RM, Wagner GS. Diagnostic and prognostic significance of mini-mally elevated creatine kinase-MB in suspected acute myocardial infarction. Am J Cardiol 1985; 55: 1478-84.
128. Hackel DB, Reimar KA, Ideker RE, et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation 1984; 70: 824-35.
129. Roberts R. Enzymatic estimation of infarct size Thrombolysis induced its demise: will it now rekindle its renais-sance? Circulation 1990; 81: 707-10.
130. Kawaguchi K, Sone T, Tsuboi H, et al Quantitative estimation of infarct size by simultaneous dual radionuclide single photon emission computed tomography: comparison with peak serum creatine kinase activity Am Heart J 1991; 121: 1353-60.
131. Omura T, Teragaki M, Tani T, et al. Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction. Jpn Circ J 1993; 57: 1062-70.
132. Devries SR, Jaffe AS, Geltman EM, Sobel BE, Abendschein DR. Enzymatic estimation of the extent of irreversible myocardial injury early after reperfu-sion. Am Heart J 1989; 117: 31-6.
133. Groth T, Hakman M, Sylven C. Prediction of myocardial infarct size from early serum myoglobin observa-tions. Scand J Clin Lab Invest 1987; 47: 599-603.
134. Yamashita T, Abe S, Arima S, et al. Myocardial infarct size can be esti-mated from serial plasma myoglobin measurements within 4 hours of re-perfusion. Circulation 1993, 87: 1840-9.
135. Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous throm-bolysis. Circulation 1993; 87: 1542-1550.
136. Puleo PR, Perryman MB. Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB sub-forms. J Am Coll Cardiol 1991, 17: 1047-52.
137. Laperche T, Steg PG, Dehoux M, et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers. Circulation 1995; 92: 2079-86
138. Lott JA. Serum enzyme determina-tions in the diagnosis of acute myo-cardial infarction: an update. Hum Pathol 1984;15: 706-16.
139. Adams JD, Bodor GS, Davila RV, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88: 101-6.
140. Karlsberg RP, Roberts R. Effect of altered thyroid function in plasma creatine kinase clearance in the dog. Am J Physiol 1978; 235: 614-618.
141. Hällgren R, Cullhed I, Roxin LE, Venge P. Myoglobinemia after myocardial infarction; influence of renal function. Eur J Cardiol 1978; 8: 607-16.
142. Kobayashi S, Tanaka M, Tamura N, Hashimoto H, Hirose S. Serum cardiac troponin T in polymyositis/derma-tomyositis. Lancet 1992; 340: 8821.
143. Katus HA, Haller C, Muller BM, Scheffold T, Remppis A. Cardiac troponin T in end-stage renal disease patients undergoing chronic main-tenance hemodialysis. Clin Chem 1995; 41: 1201-2.
144. Dillon MC, Calbreath DF, Dixon AM, et al. Diagnostic problem in acute myocardial infarction: CK-MB in the absence of abnormally elevated total creatine kinase levels. Arch Intern Med 1982; 142: 33-8.
145. AdamsJ,Trent R, Rawles J. Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. The GREAT Group. Br Med J 1993; 307: 409-13.
146. Selwyn AP, Fox K, Welman E, Shillingford JP. Natural history and evolution of Q-waves during acute myocardial infarction. Br Heart J 1978; 40. 383-87.
147. Haiat R, Chiche P. Transient abnormal Q waves in the course of ischemic heart disease. Chest 1974, 65: 140-44.
148. Boden WE, Gibson RS, Schechtman KB, et al. ST segment shifts are poor predicvtors of subsequent Q wave evolution in acute myocardial infarction. A natural history study of early non-Q wave infarction. Circulation 1989; 79: 537-548.
149. Yusuf S, Pearson M, Sterry H, et al The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial in-farction. Eur Heart J 1984; 5: 690-6.
150. McGuiness JB, Begg TB, Semple T. First electrocardiogram in recent myo-cardial infarction. Br Med J 1976; 2: 449.
151. Cohen M, Scharpf S, Rentrop K. Pro-spective analysis of electrocardio-graphic variables as markers for extent and location of acute wall motion ab-normalities observed during coronary angioplasty in human subjects. J Am Coll Cardiol 1987; 10 17.
152. Mauri F, Gasparini M, Barbonaglia L, et al. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial). Am J Cardiol 1989; 63: 1291-5.
153. Cohen M, Hawkins L, Greenberg S, Fuster V. Usefulness of ST-segment changes in greater than or equal to 2 leads on the emergency room electro-cardiogram in either unstable angina pectoris or non-Q-wave myo-cardial infarction in predicting outcome. Am J Cardiol 1991; 67: 1368-73.
154. Karlsson JE, Bjorkholm A, Blomstrand P, Ohlsson J, Wallentin L. Ambulatory ST-recording has no additional value to exercise test for identification of severe coronary lesions after an episode of unstable coronary artery disease in men. Int J Card Imaging 1993; 9: 281-9.
155. Krucoff MW, Croll MA, Pope JE, et al. Continuous 12-lead ST-segment recovery analysis in the TAMI7 study. Performance of a noninvasive method for real-time detection of failed myo-cardial reperfusion. Circulation 1993; 88: 437-46.
156. Dellborg M, Steg PG, Simoons M, et al. Vectorcardiographic monitoring to assess early vessel patency after reper-fusion therapy for acute myo-cardial infarction. Eur Heart J 1995; 16. 21-9.
157. Lundin P, Eriksson SV, Strandberg LE, Rehnqvist N. Prognostic information from on-line vectorcardiography in acute myocardial infarction. Am J Cardiol 1994; 74. 1103-8.
158. Patel DJ, Holdright DR, Knight CJ, et ai. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 1996; 75: 222-228.
159. Andersen K, Eriksson P, Källström G, Alveren E, Svensson A-M, Dellborg M. Contineuous vectorcardiography predicts clinical events in patients with unstable coronary disease. Eur Heart J 1996; 17: 575 (abstract)
160. Lundin P, Eriksson SV, Fredrikson M, Rehnqvist N. Prognostic information from on-line vectorcardiography in unstable angina pectoris. Cardiology 1995; 86: 60-6.
161. Butman S, Olson H, Butman L. Early exercise testing after stabilization of unstable angina: Correlation with coronary angiographic findings and subsequent cardiac events. Am Heart J 1986; 111: 11-18.
162. Swahn E, Areskog M, Berglund U, Walfridsson H, Wallentin L. Predictive importance of clinical findings and a predischarge exercise test in suspected unstable coronary disease. Am J Cardiol 1987; 59: 208-14.
163. Wilcox I, Freedman SB, Allman KC, et al. Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol 1991; 18: 677-83.
164. Launbjerg J, Fruergaard P, Jacobsen HL, Madsen JK. Long-term risk factors from non-invasive evaluation of patients with acute chest pain, but without myocardial infarction Eur Heart J 1995; 16: 30-7.
165. Nyman I, Wallentin L, Areskog M, Areskog NH, Swahn E. Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group. Int J Cardiol 1993, 39: 131-42.
166. Swahn E, Areskog M, Wallentin L. Early exercise testing after coronary care for suspected unstable coronary artery disease - safety and diagnostic value. Eur Heart J 1986; 7: 594-601.
167. Larsson H, Areskog M, Areskog NH, et al. Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction? Int J Card Imaging 1991; 7: 7-14.
168. Juneau M, Colles P, Théroux P, et al. Symptom-limited versus low lewel exercise testing before hospital discharge after myocardial infarction. J Am Coll Cardiol 1992; 20: 927-33.
169. Krone R, Dwyer E, Greenberg H, Miller J, Gillespie J. Risk stratification in patients with first non-Q-wave infarction: Limited value of the early low-level exercise test after uncom-plicated infarcts. J Am Coll Cardiol 1989; 14: 31-37.
170. Amanullah AM, Lindvall K, Bevegard S. Prognostic significance of exercise thallium-201 myocardial perfusion imaging compared to stress echo-cardiography and clinical variables in patients with unstable angina who respond to medical treatment Int J Cardiol 1993; 39. 71-8
171. van Daele M, McNeill AJ, Fioretti PM, et al. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyrid-amole stress echocardiography for new cardiac events after an uncom-plicated myocardial infarction. J Am Soc Echocardiogr 1994; 7: 370-80.
172. Larsson H. Myocardial ischemia as a risk indikator after an episode of unstable angina or non-Q-wave myo-cardial infarction. Thesis: Linköping, 1991.
173. Schröder K, Völler H, Dingerkus H, et al. Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyri-damole, and dobutamine-atropine. Am J Cardiol 1996; 77: 909-14.
174. Picano E, Landi P, Bolognese L, et al. Prognostic value of dipyridamole echocardiography early after uncom-plicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group. Am J Med 1993; 95: 608-18
175. Amanullah A, Lindvall K. Predischarge exercise echocardiography in patients with unstable angina who respond to medical treatment. Clin Cardiol 1992; 15: 417-423.
176. Castaner A, Roig E, Serra A, et al. Risk stratification and prognosis of patients with recent onset angina. Eur Heart J 1990; 11: 868-75.
177. Ahmed WH, Bittl JA, Braunwald E. Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina. Am J Cardiol 1993; 72: 544-50.
178. Feld S, Ganim M, Carell ES, et al. Comparison of angioscopy, intra-vascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high risk patients. J Am Coll Cardiol 1996; 28: 97-105.
179. Jansson PA. Neural Networks: An overview. Analytical Chemistry 1991, 63: 357 A-362 A.
180. Baxt WG. Use of an artificial neural network for the diagnosis of myo-cardial infarction. Ann Intern Med 1991; 115: 843-8.
181. Furlong JW, Dupuy ME, Heinsimer JA. Neural network analysis of serial cardiac enzyme data A clinical app-lication of artificial machine intelli-gence. Am J Clin Pathol 1991; 96: 134-41.
182. Gillum RF, Fortman SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and stroke. Am Heart J 1984; 108: 150-158.
183. Jorgensen PJ, Horder M, Selmer J, Botker HE Analytical evaluation of a sensitive enzyme immunoassay for determinations of creatine kinase isoenzyme MB. Clin Chem 1990; 36: 1502-5.
184. Gerhardt W, Katus HA, Ravkilde J, Hamm CW. S-troponin-T as a marker of ischemic myocardial injury [letter]. Clin Chem 1992; 38: 1194-5.
185. Karlsson J-E, Björkholm A, Nylander E, Ohlsson J, Swahn E, Wallentin L. ST-changes in ECG at rest or during exercise indicate a high risk of severe coronary lesions after an episode of unstable coronary artery disease. Int J Cardiol 1993, 42; 47-55.
186. Roberts R, Kleiman NS. Earlier diagnosis and treatment of acute myo-cardial infarction necessitates the need for a 'new diagnostic mind-set'. Circulation 1994; 89. 872-81.
187. Lee TH, Juarez G, Cook EF, et al. Ruling out acute myocardial infarc-tion. A prospective multicenter validation of a 12-hour strategy for patients at low risk. N Engl J Med 1991; 324. 1239-46
188. Brunelli C, Spallarossa P, Rosettin P, Caponetto S. Recognition and treat-ment of unstable angina. Drugs 1996; 52: 196-208.
189. Jaffe AS. More rapid biochemical diagnosis of myocardial infarction. necessary? Prudent? Cost effective? Clin Chem 1993; 39. 1567-9.
190. Roxin L-E, Venge P, Wide L. A fast and sensitive radioimmunoassay of human myoglobin for use in the early diagnosis of heart infarction. Clinica Chimica Acta 1980; 107: 129-134.
191. Cairns JA, Missirlis E, Walker WH. Usefulness of serial determinations of myoglobin and creatine kinase in serum compared for assessment of acute myocardial infarction Clin Chem 1983; 29 469-73.
192. Mair J, Artner DE, Lechleitner P, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991; 37: 845-52
193. Gunnar RM, Passamani ER, Bourdillon PD, et al. Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology / American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedu-res. J Am Coll Cardiol 1990; 16: 249-92.
194. Anderson H, Dellborg M, Markenvard J, Jagenburg R, Herlitz J. [CK-MB is sufficient as a specific marker in the diagnosis of myocardial infarction]. Lakartidningen 1991; 88: 2890-2.
195. Newby LK, Gibier WB, Ohman EM, Christenson RH. Biochemical markers in suspected acute myocardial infarc-tion. the need for early assessment Clin Chem 1995; 41: 1263-5.
196. Braunwald E, Cannon C. Non-Q wave and ST segment depression myo-cardial infarction: Is there a role for thrombolytic therapy? J Am Coll Cardiol 1996; 27: 1333-34.
197. Forsström JJ, Irjala K, Selén G, et al. Using data preprocessing and single layer perceptron to analyse laboratory data. Scan J Clin Lab Invest 1995; 55 (suppl): 75-81.
198. Herlitz J, Hjalmarson A, Waldenstrom J. Time lapse from estimated onset of acute myocardial infarction to peak serum enzyme activity. Clin Cardiol 1984; 7: 433-40.
199. Murphy JJ, Connell PA, Hampton JR. Predictors of risk in patients with unstable angina admitted to a district general hospital. Br Heart J 1992; 67: 395-401.
200. Wallentin L, and the RISC group. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: Long term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. J Am Coll Cardiol 1991; 18: 1587-93.
201. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. Br Med J 1996; 313: 262-264.
202. Wu AH, Abbas SA, Green S, et al. Prognostic value of cardiac troponin T in unstable angina pectoris Am J Cardiol 1995; 76: 970-2.
203. de Winter RJ, Koster RW, Schotveld JH, Sturk A, van Straalen JP, Sanders GT. Prognostic value of troponin T, myo-globin, and CK-MB mass in patients presentering with chest pain without acute myocardial infarction. Heart 1996; 75: 235-239.
204. Cokkinos DV, Kouvaras G. Exercise testing after acute myocardial infarction. How much? How soon? Acta Cardiol 1990; 45: 75-85.
205. Nyman I. Signs and implications of ischemia in unstable coronary artery disease. Thesis: Linköping, 1993
206. Krüger D, Stierle U, Kerner W, et al. No release of troponin T after short-lasting severe myocardial ischemia. Eur Heart J 1994, 15: 221 (abstract).
207. Jurlander B, Molani MA, Balu D, Ellis AK. Serum troponin T levels predicts coronary angigraphic findings in patients with unstable angina. Circulation 1995; 92: I-679 (Abstract).
208. Kondo K, Aoki H, Ohira K, et al. Does increased serum troponin T indicate clinical severity in unstable angina? Eur Heart J 1994; 15 Abstract Supplement: 1208.
209. Wilson RF, Marcus ML, Christensen BV, Talman C, White CW. Accuracy of exercise electrocardiography in detect-ing physiologically significant coro-nary arterial lesions. Circulation 1991; 83: 412-21.
210. Lewis BS, Poole WP. The DEFIANT study of left ventricular function and exercise performance after acute myocardial infarction Doppler Flow and Echocardiology in Functional Cardiac Insufficiency: Assessment of Nisoldipine Therapy Study Group. Cardiovasc Drugs Ther 1994; 2: 407-18.